Nightingale
PrivateLast Round
IPO
Mar 19, 2021
Est. Valuation
$539.07M
Total Funding Raised
$54.63M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nightingale operates in Healthcare & Life Sciences and is based in the United States. Its latest recorded funding round was a Private Equity round in January 2021.
Nightingale is a healthcare technology company that provides a full-stack operating system designed to launch and manage full-risk Accountable Care Organizations (ACOs).
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Healthcare Analytics, Revenue Cycle, Workflow Automation, Compliance & Risk
Business Model
B2B
Customer Profile
Revenue Share, Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nightingale Comparables
Compare Nightingale with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aledade | 81% | |
| IQVIA Holdings Inc. | 77% | |
| Vytalize Health | 77% |
For institutional investors. Book with your work email.
Nightingale Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Mar 19, 2021 | ||||
| Private Equity | Jan 20, 2021 | ||||
| Strategic | Nov 15, 2019 | ||||
| Debt | Jan 18, 2019 | ||||
| Strategic | Mar 1, 2018 | ||||
Series B | Oct 3, 2016 |
For institutional investors. Book with your work email.
Nightingale Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| COR Group | Series B, Series A |
| AP4 (The Fourth Swedish National Pension Fund) | IPO |
| Sp-Rahastoyhtiö Oy | IPO |
| European Investment Bank Group | Debt |
| FIM Varainhoito Oy | IPO |
| DNCA Investments | IPO |
| Finnvera | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 55% MoM.
- Apr 24, 2026
Monthly visitors increased 79% MoM.
For institutional investors. Book with your work email.
Nightingale Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nightingale's valuation, stock price, and market status.
Is Nightingale a public or private company?
Nightingale is a private company.
What is the current stock price of Nightingale?
Nightingale is a private company, so its shares have no public market price. Caplight tracks Nightingale's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nightingale worth (valuation)?
Nightingale's valuation is estimated at $539.1M based on funding round data.
Can I buy Nightingale stock?
Nightingale shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nightingale's last funding round?
Nightingale's most recent funding round was IPO on March 19, 2021.
Who are the main investors in Nightingale?
Key investors in Nightingale include COR Group, European Investment Bank Group.
Will Nightingale IPO soon?
No public IPO plans have been announced for Nightingale.
How can I track Nightingale secondary market activity?
Caplight tracks bids, offers, and trades in Nightingale's shares on secondary markets.